
Gemini Pharmaceuticals Limited
Produces pharmaceuticals and medicinal products using chemicals and plants.
Produces pharmaceuticals and medicinal products using chemicals and plants.
Gemini Pharmaceuticals Limited (GPL) is a Public Limited Indian Non-Government Company incorporated in India on 02 August 2005 and has a history of 19 years and eight months. Its registered office is in Muzaffarnagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.20 Cr.
The company currently has active open charges totaling ₹5.27 Cr.
Ajay Sharma, Sudhir Kumar, Kuwar Singh, and One other member serve as directors at the Company.
Muzaffarnagar, Uttar Pradesh, India
+91-XXXXXXXXXX
U24232UP2005PLC030446
030446
Public Limited Indian Non-Government Company
02 Aug 2005
30 Sep 2024
31 Mar 2024
Unlisted
Roc Kanpur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajay Sharma ![]() | Additional Director | 21-Feb-2012 | Current |
Sudhir Kumar ![]() | Director | 01-Oct-2016 | Current |
Kuwar Singh ![]() | Additional Director | 15-Apr-2016 | Current |
Ramdev ![]() | Additional Director | 25-Mar-2023 | Current |
Gemini Pharmaceuticals Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.43% decrease. The company also saw a substantial improvement in profitability, with a 73.92% increase in profit. The company's net worth moved up by a moderate rise of 4.4%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Gemini Pharmaceuticals had a promoter holding of 25.64% and a public holding of 74.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ajay Sharma, Kuwar Singh and 1 more are mutual person
Ajay Sharma, Sudhir Kumar and 2 more are mutual person
Kuwar Singh and Ramdev are mutual person
Kuwar Singh is a mutual person
Kuwar Singh and Ramdev are mutual person
Kuwar Singh is a mutual person
₹5.27 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
04 May 2006 | State Bank Of India | ₹5.27 Cr | Open |
Gemini Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gemini Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gemini Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gemini Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Gemini Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Ramdev was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2023 & has been associated with this company since 2 years 21 days .
Sudhir Kumar was appointed as a Director was appointed as a Director on 01 Oct 2016 & has been associated with this company since 8 years 6 months .
Kuwar Singh was appointed as a Additional Director was appointed as a Additional Director on 15 Apr 2016 & has been associated with this company since 8 years 11 months .
Ajay Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 21 Feb 2012 & has been associated with this company since 13 years 1 month .
Gemini Pharmaceuticals Limited was incorporated on 02 Aug 2005.
The authorized share capital of Gemini Pharmaceuticals Limited is ₹ 2.25 Cr and paid-up capital is ₹ 2.20 Cr.
Currently 4 directors are associated with Gemini Pharmaceuticals Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Gemini Pharmaceuticals Limited is 19-A, New Mandi India, Muzaarnagar, Uttar Pradesh, 251001.
The corporate identification number (CIN) of Gemini Pharmaceuticals Limited is U24232UP2005PLC030446 and the company number is 030446 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Gemini Pharmaceuticals Limited has fallen by -9.43%.
The financial reports for the fiscal year 2022 indicates that The net worth of Gemini Pharmaceuticals Limited has experienced an upsurge of 4.40%.
As per the financial statements for fiscal Year 2022, The total open charges for Gemini Pharmaceuticals Limited amount to ₹ 5.27 Cr.
The most recent Balance Sheet for Gemini Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
AG
AG
DG
SM
NS
AK
MK
VK